Apoptotic and morphological features of the umbilical artery endothelium in mild and severe pre-eclampsia

Acta Obstetricia et Gynecologica Scandinavica

Volumn 85, Issue 9, 2006, Pages 1038-1045

  Yulǔg, Esin ^a   Yenilmez, Engin ^a   Unsal, Mesut A ^a   Aydin, Sevim ^a   Tekelioglu, Yavuz ^a   Arvas, Haluk ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Endothelium; Microscopy; Pre eclampsia; Umbilical artery

Indexed keywords

ADULT; APOPTOSIS; ARTERY ENDOTHELIUM; ARTICLE; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ELECTRON MICROSCOPY; ENDOPLASMIC RETICULUM; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; MICROSCOPY; MITOCHONDRION; NICK END LABELING; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; UMBILICAL ARTERY;

ADULT; APOPTOSIS; CASE-CONTROL STUDIES; CYTOPLASM; ENDOPLASMIC RETICULUM, ROUGH; ENDOTHELIUM, VASCULAR; FEMALE; FLOW CYTOMETRY; GESTATIONAL AGE; HUMANS; IN SITU NICK-END LABELING; MICROSCOPY, ELECTRON; MITOCHONDRIA; PRE-ECLAMPSIA; PREGNANCY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; UMBILICAL ARTERIES;

EID: 33747798719     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340600753133     Document Type: Article

References (23)

1. Gilabert R, Bellart J, Jove M, Miralles RM, Piera V. Endothelial cell lesion in preeclampsia. Morphofunctional study using umbilical endothelial cells. Gynecol Obstet Invest. 1999;47:95-101.
2. Gonzales-Quintero VH, Smarkusky LP, Jimenez JJ, Mauro LM, Jy W, Hortsman LL, et al. Elevated plasma endothelial microparticles: preeclampsia versus gestational hypertension. Am J Obstet Gynecol. 2004;191:1418-24.
3. Verhaar MC, Rabelink TJ. The endothelium: a gynecological and obstetric point of view. Eur J Obstet Gynecol Reprod Biol. 2001;94:180-5.
4. Wang Y, Gu Y, Zhang Y, Lewis DF. Evidence of endothelial dysfunction in preeclampsia: decreased endothelial nitric oxide synthase expression is associated with increased cell permeability in endothelial cells from preeclampsia. Am J Obstet Gynecol. 2004;190:817-24.
5. Roberts JM, Taylor RN, Goldfien A. Endothelial cell activation as a pathogenetic factor in preeclampsia. Semin Perinatol. 1991;15:86-93.
6. Takacs P, Kauma SW, Sholley MM, Walsh SW, Dinsmoor MJ, Green K. Increased circulating lipid peroxides in severe preeclampsia activate NF-kappaB and upregulate ICAM-1 in vascular endothelial cells. FASEB J. 2001;15:279-81.
7. Berk BC, Alexander RW, Brock TA, Gimbrone MA Jr, Webb RC. Vasoconstriction: a new activity for platelet-derived growht factor. Science 1986; 232: 87-90.
8. Bellart J, Gilabert R, Cabero L, Fontcuberta J, Monasterio J, Miralles RM. Heparin cofactor II: a new marker for preeclampsia. Blood Coagul Fibrinolysis. 1998;9:205-8.
9. Friedman SA, de Groot CJ, Taylor RN, Golditch BD, Roberts JM. Plasma cellular fibronectin as a measure of endothelial involvement in preeclampsia and intrauterine growth retardation. Am J Obstet Gynecol. 1994;170:838-41.
10. Wang X, Yi S, Athayde N, Trudinger B. Endothelial cell apoptosis is induced by fetal plasma from pregnancy with umbilical placental vascular disease. Am J Obstet Gynecol. 2002;186:557-63.
11. Kim HS, Hwang KK, Seo JW, Kim SY, Oh BH, Lee MM, et al. Apoptosis and regulation of Bax and Bcl-X proteins during human neonatal vascular remodeling. Arterioscler Thromb Vasc Biol. 2000;20(4):957-63.
12. Hernandez EP, Botero TM, Mantellini MG, McDonald HJ, Nor JE. Effect of ProRoot MTA mixed with chlorhexidine on apoptosis and cell cycle of fibroblasts and macrophages in vitro. Int Endod J. 2005;38:137-43.
13. Luo T, Xia Z, Ansley DM, Ouyang J, Granville DJ, Li Y, et al. Propofol dose-dependently reduces tumor necrosis factor-alpha-induced human umbilical vein endothelial cell apoptosis: effects on Bcl-2 and Bax expression and nitric oxide generation. Anesth Analg. 2005;100:1653-9.
14. Pugnaloni A, Salvolini E, Lucarini G, Staffolani R, Cester N, Mazzanti L, et al. The human umbilical vein in normal, hypertensive and diabetic pregnancies: immunomorphological and ultrastructural evidence. Gynecol Obstet Invest. 1995; 39:239-46.
15. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem. 1983;31:1333-5.
16. Riley RS, Mahin EJ, Ross W. DNA ploidy and cell cycle analysis. In: Riley RS, Mahin EJ, Ross W, editors. Clinical Applications of Flow Cytometry, Chapter 6. New York: Igaku-Shoin Medical Publishers; 1993. p. 251-321.
17. Inan S, Sanci M, Can D, Vatansever S, Oztekin O, Tinar S. Comparative morphological differences between umbilical cords from chronic hypertensive and preeclamptic pregnancies. Acta Med Okayama. 2002;56:177-86.
18. Dadak C, Ulrich W, Sinzinger H. Morphological changes in the umbilical arteries of babies born to preeclamptic mothers: an ultrastructural study. Placenta. 1984;5:419-26.
19. Sulbaran TA, Castellano A, Chacin L, Vergel C, Portillo MA, Urbina E, et al. Electron microscopy of umbilical cord endothelial cells in preeclampsia. J Submicrosc Cytol Pathol. 2002;34:389-95.
20. Çetin A, Kukner A, Ozturk F. Ultrastructure of human umbilical vessels in pre-eclampsia. J Matern Fetal Neonatal Med. 2002;12:178-84.
21. Cummings MC, Winterford CM, Walker NI. Histology for pathologists. In: Sternberg SS, editor. Apoptosis, Chapter 1. New York: Lippincott-Raven; 1997. p. 3-9.
22. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 1995;267:1456-62.
23. Spinillo A, Bergante C, Gardella B, Mainini R, Montanari L. Interaction between risk factors for fetal growth retardation associated with abnormal umbilical artery Doppler studies. Acta Obstet Gynecol Scand. 2004;83:431-5.